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1. Introduction 
1.1 T helper cell subset 
Helicobacter pylori (H. pylori) and smoking are well known risk factors for gastric ulcer, and 
both are classified as definite carcinogens. Interestingly, the two also reportedly share 
common immune response features.  
With recent advances in immunology, various functions of T lymphocytes (T cells) have 
been discovered. T cells are divided into suppressor and helper on the basis of 
immunological functionings, and T helper cells are now known to consist of two distinct 
groups, as demonstrated using mouse models in the 1980s [Reiner, 2008; Mosman & 
Coffman, 1989]. Both groups are derived from naïve T cells: interleukin-12 (IL-12) causes 
naïve T helper cells to differentiate into type 1 (Th1) cells, while augmentation of IL-4 
around naïve T cells leads to Th2 differentiation. Th1 cells produce IL-2 and interferon- γ 
(IFN-γ) to maintain cell mediated immunity against intracellular organisms such as viruses 
and mycobacteria, and Th2 cells produce IL-4 and IL-13 promoting the differentiation of B 
cells to plasma cells and the induction of class-switching resulting in IgE production. 
Differentiated plasma cells produce immunoglobulins which participate in mucosal defense 
against extracellular organisms including H. pylori. Groundbreaking research inspired 
subsequent studies which finally led to the discovery of Th17 cells [Steinman, 2007] and T 
regulatory cells (Treg) [Sakaguchi et al., 1995, 2008]. As a consequence of this pioneering 
research, T helper cells, at present, are sub-grouped into 4 types according to the differences 
in their cytokine productions (Table 1).  
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Table 1. T helper subsets 
 
Inductive, Selective 
T helper subset Cytokines Secreted Cytokines 
Th1* IL-12, IFN- γ IL-2, TNF, IFN- γ 
Th2** L-4, IL-33 IL-4, IL-5, IL-6, IL-9, 
  IL-10, IL-13, IL-25 
Th17 TGF-β, IL-6, IL-23 IL-17, IL-6, IL-22, TNF 
Treg  TGF- β, IL-10 TGF- β IL-10, CTLA4 
Table 1a. Subsets of T helper cells and related cytokines 
 
T helper subset Protection Pathology 
Th1* Defense against Inflammation 
 intracellular organisms  
Th2** Defense against 
extracellular bacteria at 
mucosal and epithelial 
surface 
Allergy 
Th17 Defense against Autoimmunity 
 extracellular bacteria Cancer 
Treg Suppression of Anti-inflammation 
 immune response  
Concept of Th1 and Th2 cells originate from the cytokine production pattern of murine T cells. 
Therefore attention such differences is necessary when considering human immunity.   
*Exert cell mediated immunity 
**Exert humoral immunity 
CTLA4: Cytotoxic T lymphocyte antigen 4 
IFN: Interferon 
IL: Interleukin 
TGF: Tumor growth factor 
TNF: Tumor necrosis factor 
Table 1: Table by Reiner modified by authors (ref. 1 p412) 
Table 1b. Roles of each T helper subset 
Th1 cells produce IL-2, IFN- γ, tumor growth factor-β(TGF- β) and so on, thereby exerting 
cell mediated immunity mainly through IFN- γ. 
Th2 cells produce IL-4, IL-5, IL-6, IL-9, IL-10, IL-13, and so on, thereby up-regulating humoral 
immunity against extracellular pathogens and inducing allergy mainly through IL-4.  
Th17 cells produce IL-17A, IL-17F, IL-22 and so on, thereby eradicating bacterial/fungal 
infections and might be related to autoimmunity and cancer. Th17 cells produce inflammatory 
cytokines, and over-expression of such cytokines is associated with autoimmune diseases such 
as type 1 diabetes, inflammatory bowel disease, rheumatoid arthritis, and multiple sclerosis. 
IL-6 and TGF- β are key cytokines for differentiation into Th17. 
Treg produces TGF- β, IL-10, and cytotoxic T lymphocyte antigen 4 (CTLA4), and suppress 
activated T cells/dendritic cells. Treg can suppress Th1, Th2, and Th17 to terminate immune 
responses/inflammation and also plays crucial roles in immune tolerance [Sakaguchi et al., 
1995, 2008].  
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As stated above, Th1 cells can down-regulate immunoglobulin production through 
secretion/production of IFN-γ whereas Th2 cells IL-4-dependently up-regulate 
immunmoglobulin secretion/production.  
1.2 Th1 response in patients with peptic ulcer 
As to gastric and duodenal ulcers, H. pylori infection has increasingly been reported to exert 
a Th response on type 1 (Th1 cells) [Hida et al., 1999; Holck et al.; 2003; D’Elios et al., 1997, 
2003,2005; Itoh et al., 2005; Goll et al., 2007; Ayada et al., 2009; Mohammadi et al., 1996; Fan et 
al., 1998; Bamford et al., 1998; sommer et al., 1998; Lindholm et al., 1998; Ihan et al., 2000; 
Smythies et al., 2000; Akhiani et al., 2002; Guiney et al., 2003; Amedei et al., 2006; Taylor et al, 
2006], and peptic ulcer disease has also been increasingly reported to produce Th1 skew 
[Hida et al., 1999; D’Elios et al., 2007; Goll et al., 2008; Codolo et al., 2008; Del Prete et al., 2008; 
Shimada et al., 2008; Watanabe et al., 2010; Hosseini et al., 2010]. In addition, a unique study 
conducted by Itoh et al. suggested Th1 polarization of gastric T cells in the antrum of 
dyspeptic pateints, irrespective of H. pylori infection [Itoh et al, 1999].  
1.3 Th1 response in patients with H. pylori infection 
H. pylori has increasingly been reported to show Th1 predominance [Mohammadi et al., 
1996; D’Elios et al., 1997, 2003,2005; Bamford et al., 1998; Fan et al., 1998; Lindholm et al., 
1998; Sommer et al., 1998; Hida et al., 1999; Ihan et al., 2000; Smythies et al., 2000; Akhiani et 
al., 2002; Guiney et al., 2003; Holck et al.; 2003; Itoh et al., 2005;  Amedei et al., 2006; Taylor et 
al, 2006; Goll et al., 2007; Ayada et al., 2009] with only a few studies obtaining opposing 
results [Bergman et al., 2004; Campbell et al., 2004; Kayhan et al., 2008; Kido et al., 2010]. 
Therefore, H. pylori is presumed to down-regulate immunoglobulin production/secretion.  
1.4 Influence of smoking on serum immunoglobulins and Th response 
Smoking has been reported to suppress serum immunoglobulin levels [Andersen et al., 1982; 
Tollerud et al., 1995; Barbour et al., 1997; Gonzalez-Quintela et al., 2007] and some studies 
have indicated a Th1 skew in smokers [Hallquist et al., 2000; Whetzel et al., 2007; Kikuchi et 
al., 2008], although controversial data have also been reported [Hagiwara et al., 2001; Zeidel 
et al., 2002; Cozen et al., 2004].  
1.5 Possible mechanisms by which H. pylori infection induces Th1 skew 
Although a Th1 skew in H. pylori-infected patients is suggested by the vast majority of 
research conducted on this subject, the precise mechanism by which Th1 differentiation is 
induced has yet to be elucidated. However, some investigators have conducted crucial 
studies that may explain this phenomenon: Eaton et al. reported CD4+ T cells to be essential 
for the development of H. pylori-induced gastritis [Eaton et al., 2001], and Nagai et al. 
showed the coccoid form of H. pylori to reach to Peyer’s patches and then be phagocytosed 
by dendritic cells thereby sensitizing CD4+ T cells, and that these sensitized CD4+ T cells 
homed to the lamina propria of the gastric mucosa [Nagai et al., 2007]. Finally, such 
dendritic cells produce IL-12 which promotes Th1 differentiation after phagocytosis of H. 
pylori [Codolo et al., 2008]. 
In addition to mentioned above, a number of investigators have demonstrated a Th1 skew in 
patients with peptic ulcers, as compared to those with gastritis or gastric cancer [Hida et al., 
1999; D’Elios et al., 2007; Goll et al., 2008; Codolo et al., 2008; Del Prete et al., 2008; Shimada et 
al., 2008; Hosseini et al., 2010; Watanabe et al., 2010].  
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We therefore conducted the current study to assess the influence of both H. pylori and 
smoking on serum immunoglobulin levels for the purpose of evaluating the presence of Th1 
skew in patients with peptic ulcers. 
2. Patients and method 
2.1 Study design 
Study 1. Effects of current smoking on levels of serum immunoglobulins 
To evaluate the influences of smoking on serum immunoglobulin levels, serum IgG, IgA, 
and IgM levels were measured in both peptic ulcer and non-ulcer gastritis patients with and 
without H. pylori infection. 
Study 2. Effects of H. pylori infection on levels of serum immunoglobulins in peptic ulcer 
patients 
To evaluate the influences of H. pylori infection on serum immunoglobulin levels, serum 
IgG, IgA, and IgM were measured in peptic ulcer patients, both current smokers and non-
smokers. 
Study 3. As a control for study 2, serum IgG, IgA, and IgM levels were measured in non-
ulcer gastritis patients with and without current smoking. 
2.2 Patients 
Dyspeptic patients and those recommended to undergo fiberscopic examination received 
gastroduodenoscopic examinations. Those endoscopically diagnosed as having gastric or 
duodenal ulcers were included in the current study. Following informed consent to check H. 
pylori status and immunohematologic parameters, dyspeptic patients underwent 
gastrofiberscopic examination. Patients with hematologic, immunologic, rheumatic, 
malignant, and infectious diseases were excluded. Those taking corticosteroids, antibiotics, 
and/or immunosuppressive drugs were also excluded. Because non-steroidal anti-
inflammatory drugs (NSAIDs) [Franch et al, 1994; Mazzeo et al., 1998; Yamaki et al., 2003, 
2005; Andreone et al., 2004; Mored et al., 2004] and proton-pump inhibitors (PPIs) [Tsutsumi 
et al., 2005; Matsukawa et al., 2007] have increasingly been reported to skew the T helper 
response toward type 2, patients taking these drugs were also excluded. Both smokers and 
non-smokers with endoscopically diagnosed non-ulcer gastritis were also evaluated as 
control groups. 
2.3 Methods   
Following informed consents to measure titers of serum anti-H. pylori IgG antibody, serum 
immunoglobulins and complete blood cell counts, patients with gastric or duodenal ulcer 
was diagnosed according to the classification of Sakita and Miwa [Matsukawa et al., 1997], 
and those with non-ulcer gastritis did according to the updated Sydney System [Dixon et al., 
1996] under gastrofiberscopic observation. To evaluate H. pylori status, biopsy specimens 
were obtained from the antrum and lower body of the greater curvature in the stomach and 
from the major lesions. The samples from the antrum and lower body were placed in rapid 
urease test (RUT) kits, and the results were evaluated 24 hr later. These samples were also 
prepared for pathologic evaluation. Immediately after completion of the procedure, blood 
samples were collected to measure IgG, IgA, IgM, and anti-H. pylori IgG antibodies. Serum 
levels of IgG, IgA, and IgM were measured by an automated turbidimetric 
immunoprecipitation method [Matsukawa et al., 1997], and the anti-H. pylori antibody was 
measured by a commercially available ELISA kit. Confirmed H. pylori infection required 
www.intechopen.com
Helicobacter pylori Suppresses Serum Immunoglobulin Levels in Smokers with Peptic Ulcer:  
Probable Interaction Between Smoking and H. pylori Infection in the Induction of Th1… 
 
229 
both RUT and anti-H. pylori IgG antibody to be positive. Smoking status was ascertained on 
the day of the endoscopic examination.  
2.3.1 Statistical analysis 
Data were expressed as means+/-SD. The statistical significance of differences was anlyzed 
employing the Student unpaired t-test and the -square test. We evaluated statistical 
differences using Macintosh StatView version 4, and p values less than 0.05 were accepted 
as statistically significant.  
3. Results 
3.1 Recruited patients and controls  
Table 2. Profiles of patients and controlls  
 
Sex Female Male 
Number 90 146 
Age (years)** 60.0+/-11.5 53.4+/-13.6 
H. pylori* 66 (73.3%) 127 (87.0%) 
Smokers* 24 (37.5%) 82 (56.2%) 
Table 2a. Profiles of patients with peptic ulcer  
 
Sex Female Male 
Number 408 312 
Age (years) 56.6+/-14.3 55.8+/-13.3 
H. pylori* 229 (56.1%) 192 (61.1%) 
Smokers* 44 (10.8%) 106 (34.0%) 
Smokers: peptic ulcer>non-ulcer gastritis (female.=0001 and male <.0001) 
H. pylori prevalence: peptic ulcer>non-ulcer gastritis (<.0001 for females and males) 
*P<.0001 **P=.0001   
Table 2b. Profiles of patients with non-ulcer gastritis  
There were 146 patients with gastric ulcer, 58 with duodenal ulcer, and 32 with both types 
(Table 3). There were no differences in these lesions between smokers and non-smokers.  
 
Smokers (F:M)    
Body Angle/Antrum Duodenum Multiple 
33 (7:26) 30(10:20) 28 (2:26) 15 (5:10) 
Non-smokers (F:M)    
Body Angle/Antrum Duodenum Multiple 
51 (32:19) 32(15:17) 30 (15:15) 17 (5:12) 
Total    
Body Angle/Antrum Duodenum Multiple 
84 (39:45) 62(25:37) 58 (17:41)   32 (10:22) 
Table 3. Ulcer location (F:M) 
Table 2 presents the profiles of both patients with peptic ulcer and those with non-ulcer 
gastritis serving as controls. In total, 236 patients (F:M=90:146) were diagnosed as having 
gastric and/or duodenal ulcers and were enrolled in this study. There was an age difference 
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between female and male patients (F:M=60.0+/-11.5 vs. 53.4+/-13.6 years, p=.0001) (Table 
2a). Patients with non-ulcer gastritis consisted of 408 females and 312 males, and there was 
no difference in age between genders (56.6+/-14.3 vs. 55.8+/-13.3 years) (Table 2b).  
Patients with peptic ulcer had higher prevalences of both H. pylori infection and smoking, as 
compared to those with non-ulcer gastritis: p=.0001 for smoking in females and <.0001 for 
smoking in males, while p<.0001 for H. pylori infection in both females and males (Tables 2a 
and 2b). 
3.2 Serum levels of IgG, IgA, and IgM in the current study 
3.2.1 The results of study 1 
Tables 4 and 5 show the results of study 1, examining the effects of current smoking on 
serum immunoglobulin levels in patients with petic ulcer and non-ulcer gastritis. There was 
age difference between smokers and non-smokers with H. pylori infection among ulcer 
patients (p=.0019). Smoking was associated with definite suppressions of serum IgG, IgA, 
and IgM levels in H. pylori-infected patients with peptic ulcer (p<.0001, .0006, and .0009, 
respectively), whereas ulcer patients without H. pylori infection showed no such tendency. 
Table 5 presents the effects of current smoking on serum immunoglobulin levels in non-
ulcer patients with gastritis. There was an age difference between smokers and non-smokers 
(p<.0001). Among patients with non-ulcer gastritis, smokers had suppressed serum IgG 
(p<.0001), IgA (p<.05), and IgM levels, although the reduction of IgM in patients with H. 
pylori infection failed to reach statistical significance. Like those with H. pylori infection, non-
ulcer patients without H. pylori infection also showed suppression of both IgG and IgM 
(p<.05, respectively). 
Table 4. Influence of smoking on serum immunoglobulin levels in peptic ulcer patients 
 
 Smokers Non-smokers P 
N 92 101  
Age 52.2+/-12.2 58.0+/-13.2 .0019 
IgG 1178.0+/-250.3 1376.6+/-343.2 <.0001 
IgA 218.4+/-98.2 271.4+/-109.1 .0006 
IgM 93.8+/-41.9 123.1+/71.1 .0009 
Table 4a. Serum immunoglobulin levels in H. pylori-infected patients 
 
 Smokers Non-smokers P 
N 14 29  
Age 56.0+/-13.7 60.7+/-13.7 NS 
IgG 1348.6+/-254.7 1463.7+/-286.3 NS 
IgA 295.1+/-113.2 253.2+/-99.3 NS 
IgM 105.8+/-49.8 123.5+/47.9 NS 
IgG: Immunoglobulin G (mg/dl) 
IgA: Immunoglobulin A (mg/dl) 
IgM: Immunoglobulin M (mg/dl) 
N: Number of patients 
NS: Not significant 
P: Probability 
Table 4b. Serum immunoglobulin levels in patients without H. pylori infection  
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Table 5. Effects of smoking on serum immunoglobulin levels in non-ulcer gastritis patients 
 
 Smokers Non-smokers P 
N 93 325  
Age 53.5+/-11.6 60.0+/-11.4 <.0001 
IgG 1224.1+/-264.3 1392.1+/-278.6 <.0001 
IgA 236.6+/-97.0 264.0+/-112.7 .0384 
IgM 104.7+/-58.6 112.4+/63.5 NS 
Table 5a. Serum immunoglobulin levels in H. pylori-infected patients  
 Smokers Non-smokers P 
N 57 247  
Age 51.9+/-13.4 57.8+/-13.9 .0071 
IgG 1205.5+/-278.6 1295.0+/-237.7 .0228 
IgA 254.7+/-118.3 251.0+/-89.7 NS 
IgM 83.4+/-42.9 104.8+/69.0 .0408 
IgG: Immunoglobulin G (mg/dl) 
IgA: Immunoglobulin A (mg/dl) 
IgM: Immunoglobulin M (mg/dl) 
N: Number of patients 
NS: Not significant 
P: Probability 
Table 5b. Serum immunoglobulin levels in patients without H. pylori infection   
3.2.2 The results of study 2 








Age 52.6+/-12.2 56.0+/-13.7 NS 
IgG 1177.9+/-250.3 1348.6+/-254.7 .0197 
IgA 218.4+/-98.2 295.1+/-113.2 .0092 
IgM 93.8+/-41.9 105.8+/-49.8 NS 








Age 58.0+/-13.2 60.7+/-13.7 NS 
IgG 1376.6+/-343.3 1463.7+/-286.3 NS 
IgA 271.4+/-109.1 253.2+/-99.3 NS 
IgM 123.1+/-71.1 123.5+/-47.9 NS 
IgG: Immunoglobulin G (mg/dl) 
IgA: Immunoglobulin A (mg/dl) 
IgM: Immunoglobulin M (mg/dl) 
N: Number of patients 
NS: Not significant 
P: Probability 
Table 6b. Serum immunoglobulin levels in non-smokers  
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Table 6 presents the results of study 2, examining the effects of H. pylori infection on serum 
levels of immunoglobulins in peptic ulcer patients. As a whole, patients with peptic ulcer 
showed decreases in serum IgG, IgA, and IgM levels, although only the decrease in IgG 
reached statistical significance (data not shown). Among those with peptic ulcer, smokers 
with H. pylori infection showed decreases in both IgG and IgA (p<.0197 and .0092, 
respectively), whereas the difference in IgM did not reach statistical significance (Table 6a). 
In contrast to smokers, among patients with peptic ulcers, non-smokers with H. pylori 
infection showed no difference in IgG, IgA, or IgM levels.  
3.2.3 The results of study 3 
Table 7 presents the results of study 3, the control for study 2, examining the effects of H. 
pylori infection on serum levels of immunoglobulins in non-ulcer gastritis patients. As to the 
effect of H. pylori infection, patients with non-ulcer gastritis showed a phenomenon opposite 
to that in peptic ulcer patients, except for IgA in smokers. Patients with H. pylori infection 
had increased serum IgG, IgA, and IgM levels regardless of smoking status, although only 
the IgG difference in non-smokers (p<.0001) and the IgM difference in smokers (p=.0288) 
were statistically significant. Compared to patients with peptic ulcer, H. pylori infection, at 
minimum, did not suppress serum immunoglobulin levels regatdless of smoking status. H. 
pylori infection appeared to up-regulate serum immunoglobulin levels in non-ulcer patients 
with gastritis.   
Table 7. Effect of H. pylori infection on serum immunoglobulin levels in patients with non-
ulcer gastritis 
 
H. pylori Positive Negative P 
N 93 57  
IgG 1234.5+/-264.3 1205.5+/-278.6 NS 
IgA 236.6+/-97.0 254.7+/-111.8 NS 
IgM 104.7+/-58.6 83.4+/42.9 .0288 
Table 7a. Serum immunoglobulin levels in smokers 
 
H. pylori Positive Negative P 
N 325 247  
IgG 1392.1+/-288.7 1295.0+/-237.7 <.0001 
IgA 264.0+/-112.7 251.0+/-89.7 NS 
IgM 112.4+/-63.5 104.8+/69.0 NS 
IgG: Immunoglobulin G (mg/dl) 
IgA: Immunoglobulin A (mg/dl) 
IgM: Immunoglobulin M (mg/dl) 
N: Number of patients 
NS: Not significant 
P: Probability 
Table 7b. Serum immunoglobulin levels in non-smokers  
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We initially showed definite suppression of serum immunoglobulin levels in current 
smokers with H. pylori-associated peptic ulcer (Tables 4a), and this suppression was 
observed even in patients without H. pylori infection, although the difference did not reach 
statistical significance possibly due to our small sample size (Table 4b). In contrast to 
patients with peptic ulcer, those with non-ulcer gastritis showed suppressed levels of serum 
immunoglobulins, regardless of H. pylori status. These observations support the notion that 
smoking causes a skewed Th1 response in current smokers, regardless of whether or not H. 
pylori infection or peptic ulceration is present. As to the Th skew in smokers, there are 
conflicting reports, with some reporting a Th2 skew in smokers [Hagiwara et al., 2001; 
Zeidel et al., 2002; Cozen et al., 2004]. However, two noteworthy studies conducted recently 
have challenged this concept. Whetzel et al. reported elevated peripheral IFN-γ levels, 
especially in female smokers, and in surgically resected specimens from the colon of 
smokers [Whetzel et al., 2007], and Kikuchi et al. showed that nicotine exerted a Th1-
dominant effect via nicotinic acetylcholine receptors in the intestine [Kikuchi et al., 2008].   
As stated in the introduction, H. pylori infection is known to skew T helper differentiation 
toward type 1 (Th1) properties (production of IL-2, IFN- γ, and TNF)- thereby counteracting 
Th2-dependent processes. Th1 differentiation may reduce humoral immunity by down-
regulating immunoglobulin production resulting in suppressions of serum IgG, IgA, and 
IgM levels. H. pylori, therefore, is presumed to down-regulate serum immunoglobulin levels 
in infected individuals. On the contrary, extracellular bacterial infections usually up-
regulate IgM initially, and then IgG. Because H. pylori extracellularly colonizes the gastric 
mucosa, it should induce a Th2 response because such ubiquitous bacterium would be 
expected to colonize the mucosa (Table 1b). In accordance with this theory, Mohammadi et 
al. reported the presence of a Th2 response to effectively reduce the  bacterial load in a 
mouse model of H. pylori infection: Th1 cells enhance gastritis and Th2 cells reduce bacterial 
load [Mohammadi et al., 1997]. The current data from the control group in study 3 are also in 
accordance with this theory, i.e., H. pylori infection raises levels of serum immunoglobulins 
in both smokers (IgM) and non-smokers (IgG) with non-ulcer gastritis. This differs from the 
situation in patients with peptic ulcer, in whom H. pylori infection did not suppress serum 
immunoglobulin levels, of non-ulcer patients suggesting the unique phenomenon of Th1 
skew seen only in patients with peptic ulcer (Table 7). Taking our current observations 
together, suppression, i.e., a lack of upregulation of serum immunoglobulins appears to be a 
unique feature of smokers with both peptic ulcer and H. pylori infection. Th1 skew observed 
in H. pylori-infected patients with peptic ulcer appeared to exceed the expected Th2 skew in 
patients infected with extracellular bacteria such as H. pylori itself, especially in smokers. In 
addition, vast majority of gastric T cells may be already polarized to produce Th1 cytokine 
even in the absence of H. pylori infection [Itoh, et al., 1999]. We therefore stress that the Th1 
skew induced by H. pylori, smoking, and the presence of peptic ulceration may 
synergistically exert a Th1 response which prevails over the expected Th2 skew, i.e., up-
regulation of serum immunoglobulin levels induced by the presence of extracellular 
bacterial infection by H. pylori itself.   
The Th1 skew observed in patients with H. pylori infection indicated a Th1-polarized 
response to be associated with mucosal damage that can induce peptic ulcer, while a mixed 
Th1 and IL-4-drived Th2 polarized response appeared to be associated with a low degree of 
gastric inflammation and reduced bacterial load resulting in the prevention of ulcer 
www.intechopen.com
 
Peptic Ulcer Disease 
 
234 
formation [D’Elios et al., 1997, 2003, 2005; Mohammadi et al., 1997; Holck et al., 2003]. Th2 
drive therefore may be preferable to hasten ulcer healing in such patients. However, mixed 
or dysregulated Th responses may trigger T cell-dependent B cell activation involved in the 
development of low grade B cell lymphoma associated with H. pylori [D’Elios et al., 2003, 
2005].   
5. Conclusion 
As shown herein, current smoking is consitently associated with suppressed serum 
immunoglobulin levels (study 1), and H. pylori infection definitely reduced these levels in 
smokers with peptic ulcer (study 2). Furthermore H. pylori infection up-regulated IgG, IgA, 
and IgM in the absence of peptic ulcer. Current smoking, H. pylori infection, and the 
presence of peptic ulceration may interact to suppress the levels of serum immunoglobulins 
as a result of a Th1 shift which overwhelms the Th2 shift expected with extracellular 
bacterial infection.  
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